Immunotherapy for pythiosis: Effect on NTPDase activity in lymphocytes of an experimental model

Biomedicine and Pharmacotherapy

Volumn 64, Issue 10, 2010, Pages 718-722

  Bach, Barbara Charlotte ^a   Leal, Daniela Bitencourt Rosa ^a   Ruchel, Jader Betsch ^a   Souza, Viviane do Carmo Gonçalves ^a   Maboni, Grazieli ^a   Dal Pozzo, Marcelo ^a   Schlemmer, Karine Bizzi ^a   Alves, Sydney Hartz ^a   Santurio, Janio Morais ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

NTPDase; Pythium insidiosum; Rabbit lymphocytes

Indexed keywords

ADENOSINE TRIPHOSPHATE; APYRASE; NTPDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNE RESPONSE; IMMUNOTHERAPY; LYMPHOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; PYTHIOSIS; RABBIT;

ADENOSINE TRIPHOSPHATE; ANIMALS; HYDROLYSIS; IMMUNOTHERAPY; LYMPHOCYTES; MALE; MODELS, THEORETICAL; NUCLEOSIDE-TRIPHOSPHATASE; PYTHIOSIS; PYTHIUM; RABBITS;

EID: 78649860759     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.09.016     Document Type: Article

References (32)

1. Zimmermann H. Ectonucleotidases: some recent developments and note on nomenclature. Drug Development Research 2001, 52:44-56.
2. Leal D.B.R., Streher C.A., Neu T.N., Bittencourt F.P., Leal C.A.M., Silva J.E.P., et al. Characterization of NTPDase (NTPDase 1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes. Biochim Biophys Acta 2005, 1721:9-15.
3. Lunkes G.I., Lunkes D., Stefanello F., Morsch A., Morsch V.M., Mazzanti C.M., et al. Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thrombosis Research 2003, 109:189-194.
4. Pilla C., Emanuelli T., Frasetto S.S., Battastini A.M.O., Dias R.D., Sarkis J.J.F. ATP diphosphohydrolase activity (apyrase EC 3.6.1.5) in human blood platelets. Platelets 1996, 7:225-230.
5. Bours M.J., Swennwen E.L., Di Virgilio F., Cronstein B.N., Dagnelie P.C. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacology and Therapeutics 2006, 112:358-404.
6. Langston H.P., Ke Y., Gewirtz A.T., Dombrowski K.E., Kapp J.A. Secretion of IL-2 and IFN-γ, but not IL-4, by antigen-specific T cells requires extracellular ATP. Journal of Immunology 2003, 170:2962-2970.
7. Kobie J.J, Shah P.R., Yang L., Rebhahn J.A., Fowell D.J., Mosmann T.R. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine. Journal of Immunology 2006, 177:6780-6786.
8. Thompson L.F., Takedachi M., Ebisuno Y., Tanaka T., Miyasaka M., Mills J.H., et al. Regulation of leukocyte migration across endothelial barriers by ECTO-5'-Nucleotidase-generated adenosine. Nucleosides, Nucleotides and Nucleic Acids 2008, 27:755-760.
9. Wang T.F., Rosenberg P.A., Guidotti G. Characterization of brain ecto-apyrase: evidence for only one ecto-apyrase (CD39) gene. Molecular Brain Research 1997, 47:295-302.
10. Leal D.B.R., Streher C.A., Bertoncheli C.M., Carli L.F.D., Silva J.E.P., Morsch V.M., et al. HIV infection is associated with increased NTPDase activity that correlates with CD39-positive lymphocytes. Biochim Biophys Acta 2005, 1746:129-134.
11. De Cock A.W., Mendoza L., Padhye A.A., Ajello L., Kaufman L. Pythium insidiosum sp., the etiologic agent of pythiosis. Journal of Clinical Microbiology 1987, 25:344-349.
12. Miller R.I., Campbell R.S.F. Experimental pythiosis in rabbits. Sabouraudia 1983, 21:331-341.
13. Mendoza L., Ajello L., McGinnis M. Infections caused by the oomycetous pathogen, Pythium insidiosum. Journal de Mycologie Médicale 1996, 6:151-164.
14. Mendoza L., Mandy W., Glass W. An improved Pythium insidiosum-vaccine formulation with enhanced immunotherapeutic properties in horses and dogs with pythiosis. Vaccine 2003, 21:2797-2804.
15. Santurio J.M., Leal A.T., Leal A.B.M., Alves S.H., Lubeck I., Griebeler J., et al. Teste de ELISA indireto para o diagnóstico sorológico de pitiose. Pesquisa Veterinária Brasileira 2006, 26(1):47-50.
16. Santurio J.M., Leal A.T., Leal A.B.M., Festugatto R., Lubeck I., Sallis E.S.V., et al. Three types of immunotherapics against pythiosis insidiosi developed and evaluated. Vaccine 2003, 21:2535-2540.
17. Böyum A. Isolation of mononuclear cells and granulocytes from human blood, isolation on mononuclear cells by centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g. Scandinavian Journal of Clinical and Laboratory Investigation 1968, 97:77-89.
18. Chan K., Delfert D., Junger K.D. A direct colorimetric assay for Ca2+-ATPase activity. Analytical Biochemistry 1986, 157:375-380.
19. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
20. Miller R.I. Treatment of equine phycomycosis by immunotherapy and surgery. Australian Veterinary Journal 1981, 57:377-382.
21. Mendoza L., Villalobus J., Calleja C.E., Solis O. Evaluation of two vaccines for the treatment of pythiosis insidiosi in horses. Mycopathologia 1992, 118:89-95.
22. Mendoza L., Newton J.C. Immunology and immunotherapy of the infections caused by Pythium insidiosum. Medical Mycology 2005, 43(6):477-486.
23. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochimica et Biophysica Acta 2008, 1783(5):673-694.
24. Di Virgilio F., Boeynaems J.M., Robson S.C. Extracellular nucleotides as negative modulators of immunity. Current Opinion in Pharmacology 2009, 9(4):507-513.
25. Steinberg T.H., Di Virgilio F. Cell-mediated cytotoxicity: ATP as an effector and the role of target cells. Current Opinion in Immunology 1991, 3(1):71-75.
26. Macino B., Zambon A., Milan G., Cabrelle A., Ruzzene M., Rosato A., et al. CD45 regulates apoptosis induced by extracellular adenosine triphosphate and cytotoxic T lymphocytes. Biochemical and Biophysical Research Communications 1996, 226:769-776.
27. Correale P., Tagliaferri P., Guarrasi R., Caraglia M., Giuliano M., Marinetti M.R., et al. Extracellular adenosine-5'-triphosphate involvement in the death of LAK-engaged human tumor cells via P2X-receptor activation. Immunology Letters 1997, 55(2):69-78.
28. Coutinho-Silva R., Corrêa G., Sater A.A., Ojcius D.M. The P2X(7) receptor and intracellular pathogens: a continuing struggle. Purinergic Signaling 2009, 5(2):197-204.
29. Di Virgilio F., Ferrari D., Idzko M., Panther E., Norgauer J., La Sala A., et al. Extracellular ATP, P2 receptors, and inflammation. Drug Development Research 2003, 59(1):171-174.
30. La Sala A., Ferrari D., Di Virgilio F., Idzko M., Norgauer J., Girolomoni G. Alerting and tuning the immune response by extracellular nucleotides. Journal of Leukocyte Biology 2003, 73(3):339-343.
31. Mazzoni A., Segal D.M. Controlling the road to dendritic cell polarization. Journal of Leukocyte Biology 2004, 75:721-730.
32. Salmi M., Jalkanen S. Cell-surface enzymes in control of leukocyte trafficking. Nature Reviews. Immunology 2005, 5:760-771.